Orphan Drugs

What Are Orphan Drugs, and How Can They Be Leveraged for SCLC? – LUNGevity Foundation

LUNGevity Foundation shared a post on LinkedIn:

“What are orphan drugs, and how can they be leveraged for small cell lung cancer?

Read our latest blog with dedicated researcher and oncologist, Noura Choudhury, MD, at the University of Chicago, as she searches for better treatments for lung cancer.”

What Are Orphan Drugs, and How Can They Be Leveraged for SCLC? - LUNGevity Foundation

More posts featuring LUNGevity Foundation.